Share on StockTwits

Research Analysts’ ratings reiterations for Thursday, May 22nd:

Ashtead Group plc (LON:AHT) had its outperform rating reaffirmed by analysts at Credit Suisse. The firm currently has a GBX 1,100 ($18.50) target price on the stock.

Arrow Global Group PLC (LON:ARW) had its buy rating reaffirmed by analysts at Canaccord Genuity. They currently have a GBX 318 ($5.35) target price on the stock.

Abraxas Petroleum Corp. (NASDAQ:AXAS) had its in-line rating reissued by analysts at Imperial Capital. They currently have a $5.25 price target on the stock, down from their previous price target of $5.75.

British American Tobacco plc (LON:BATS) had its neutral rating reiterated by analysts at Credit Suisse. They currently have a GBX 3,500 ($58.87) target price on the stock.

DSW (NYSE:DSW) had its hold rating reaffirmed by analysts at Canaccord Genuity.

Electrocomponents plc (LON:ECM) had its buy rating reissued by analysts at Canaccord Genuity. The firm currently has a GBX 356 ($5.99) price target on the stock.

FirstGroup plc (LON:FGP) had its buy rating reissued by analysts at Liberum Capital. Liberum Capital currently has a GBX 155 ($2.61) price target on the stock.

Hogg Robinson Group plc (LON:HRG) had its buy rating reaffirmed by analysts at Canaccord Genuity. Canaccord Genuity currently has a GBX 110 ($1.85) price target on the stock.

Ixico Plc (LON:IXI) had its buy rating reiterated by analysts at Daniel Stewart & Co. The firm currently has a GBX 132 ($2.22) price target on the stock.

Lowe's Companies (NYSE:LOW) had its hold rating reiterated by analysts at Jefferies Group. Jefferies Group currently has a $45.00 target price on the stock, down from their previous target price of $47.00. The analysts wrote, “Despite improvement in May trends, LOW shares saw a muted stock reaction as investors focused on the wider comp gap with HD and questioned the company’s ability to still hit FY comp guidance. After adjusting for the 150 bps weather impact, LOW was below the 4% comp plan for the year when plan implied it should be above. A big Q2 will ease concerns, which will at least require recent sales momentum to flow through the rest of Q2.”

Mindray Medical International Ltd (NYSE:MR) had its hold rating reaffirmed by analysts at Jefferies Group. Jefferies Group currently has a $32.00 target price on the stock, down from their previous target price of $36.00.

Polymetal International PLC (LON:POLY) had its buy rating reissued by analysts at Canaccord Genuity. The firm currently has a GBX 670 ($11.27) price target on the stock.

Reckitt Benckiser Group Plc (LON:RB) had its outperform rating reaffirmed by analysts at Credit Suisse. They currently have a GBX 5,200 ($87.47) target price on the stock.

SABMiller plc (LON:SAB) had its hold rating reissued by analysts at Canaccord Genuity. Canaccord Genuity currently has a GBX 3,000 ($50.46) price target on the stock.

St. James's Place plc (LON:STJ) had its neutral rating reissued by analysts at Credit Suisse. Credit Suisse currently has a GBX 785 ($13.20) target price on the stock.

TG Therapeutics (NASDAQ:TGTX) had its focus list rating reaffirmed by analysts at Roth Capital.

Tiffany & Co. (NYSE:TIF) had its hold rating reissued by analysts at Jefferies Group. Jefferies Group currently has a $0.38 target price on the stock, up from their previous target price of $0.34. The analysts wrote, “Tiffany continues to execute and the numbers are still shining. The company posted beats on all fronts in 1Q with EPS ~20c above cons, driven largely by strong comps in the Americas and Asia and GM expansion. Looking ahead the outlook is better than peers, as the company is benefiting from a strong luxury cycle and global diversification. The story here remains strong, however we remain on the sidelines given valuation. Maintain Hold rating, PT to $90.”

Trina Solar Limited (NYSE:TSL) had its buy rating reiterated by analysts at Jefferies Group. The firm currently has a $23.90 price target on the stock, up from their previous price target of $23.70. The analysts wrote, “Trina Solar reported 1Q14 results with NPAT of US$27m and diluted EPS of US$0.37, above our and consensus estimates. Management guided 2Q14 shipments of 950-1,010 MW in 2Q14 and reiterated their full year guidance of 3.6-3.8GW module shipment. The company expects to complete 400-500 MW of downstream PV projects by year-end. We reiterate our Buy rating.”

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.